Form D · Other Health Care

Nymbl Science, Inc.

Denver, CO · CIK 0001781552

Offering snapshot reported Sep 12, 2025 · SEC filing

Reported sold
$984K
Offering amount: $2.35M
Investors reported
30
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Aug 29, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 12, 2025Initial$984,057No comparison30SEC filing
Dec 1, 2022Initial$8,752,476No comparison23SEC filing
Oct 7, 2020Initial$3,720,000No comparison22SEC filing
Aug 1, 2019Amendment$2,325,000$355,000vs Jul 12, 201927SEC filing
Jul 12, 2019Initial$1,970,000No comparison22SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-557472

Source: Form D, filed Sep 12, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Cook Director, Promoter
David Eichler Director
Dr. Jean Pierre Farcy Promoter
Carol Owens Jones Promoter
Edward Likovich Director, Executive
Philip Linville Director
Meghan Oliver Director
Caroline Owen Jones Promoter
Chris Saxman Director
Rohit Seth Director
Thomas Virden Director
Ben Wire Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2000 S Colorado Blvd Tower 2, Suite 320
Denver, CO, 80222